Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Oncternal Therapeutics, Inc. | c92001exv31w2.htm |
| EX-31.1 - EXHIBIT 31.1 - Oncternal Therapeutics, Inc. | c92001exv31w1.htm |
| EX-32.2 - EXHIBIT 32.2 - Oncternal Therapeutics, Inc. | c92001exv32w2.htm |
| EX-32.1 - EXHIBIT 32.1 - Oncternal Therapeutics, Inc. | c92001exv32w1.htm |
| 10-Q - FORM 10-Q - Oncternal Therapeutics, Inc. | c92001e10vq.htm |
Exhibit 12.1
GTx, Inc.
Computation of Deficiency of Earnings Available to Cover Fixed Charges
Computation of Deficiency of Earnings Available to Cover Fixed Charges
| Nine Months Ended | Year Ended December 31, | |||||||||||||||||||||||
| September 30, 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||||||||||||||||||
Loss: |
||||||||||||||||||||||||
Pretax loss from continuing operations |
$ | (35,381 | ) | $ | (51,780 | ) | $ | (40,359 | ) | $ | (35,510 | ) | $ | (36,839 | ) | $ | (22,348 | ) | ||||||
Fixed charges (from below) |
77 | 89 | 35 | 32 | 32 | 21 | ||||||||||||||||||
Total loss |
$ | (35,304 | ) | $ | (51,691 | ) | $ | (40,324 | ) | $ | (35,478 | ) | $ | (36,807 | ) | $ | (22,327 | ) | ||||||
Fixed charges: |
||||||||||||||||||||||||
Estimated interest portion of rent expenses |
$ | 77 | $ | 89 | $ | 35 | $ | 32 | $ | 32 | $ | 21 | ||||||||||||
Total fixed charges |
$ | 77 | $ | 89 | $ | 35 | $ | 32 | $ | 32 | $ | 21 | ||||||||||||
Coverage deficiency |
$ | (35,381 | ) | $ | (51,780 | ) | $ | (40,359 | ) | $ | (35,510 | ) | $ | (36,839 | ) | $ | (22,348 | ) | ||||||